Challenges for defining minimal clinically important difference (MCID) after spinal cord injury
Open Access
- 16 December 2014
- journal article
- review article
- Published by Springer Nature in Spinal Cord
- Vol. 53 (2) , 84-91
Abstract
Study design: This is a review article. Objectives: This study discusses the following: (1) concepts and constraints for the determination of minimal clinically important difference (MCID), (2) the contrasts between MCID and minimal detectable difference (MDD), (3) MCID within the different domains of International Classification of Functioning, disability and health, (4) the roles of clinical investigators and clinical participants in defining MCID and (5) the implementation of MCID in acute versus chronic spinal cord injury (SCI) studies. Methods: The methods include narrative reviews of SCI outcomes, a 2-day meeting of the authors and statistical methods of analysis representing MDD. Results: The data from SCI study outcomes are dependent on many elements, including the following: the level and severity of SCI, the heterogeneity within each study cohort, the therapeutic target, the nature of the therapy, any confounding influences or comorbidities, the assessment times relative to the date of injury, the outcome measurement instrument and the clinical end-point threshold used to determine a treatment effect. Even if statistically significant differences can be established, this finding does not guarantee that the experimental therapeutic provides a person living with SCI an improved capacity for functional independence and/or an increased quality of life. The MDD statistical concept describes the smallest real change in the specified outcome, beyond measurement error, and it should not be confused with the minimum threshold for demonstrating a clinical benefit or MCID. Unfortunately, MCID and MDD are not uncomplicated estimations; nevertheless, any MCID should exceed the expected MDD plus any probable spontaneous recovery. Conclusion: Estimation of an MCID for SCI remains elusive. In the interim, if the target of a therapeutic is the injured spinal cord, it is most desirable that any improvement in neurological status be correlated with a functional (meaningful) benefit.Keywords
This publication has 59 references indexed in Scilit:
- Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical TrialTopics in Spinal Cord Injury Rehabilitation, 2012
- Reference for the 2011 revision of the international standards for neurological classification of spinal cord injuryThe Journal of Spinal Cord Medicine, 2011
- A Systematic Review of Non-Invasive Pharmacologic Neuroprotective Treatments for Acute Spinal Cord InjuryJournal of Neurotrauma, 2011
- Assessment of Disability in Patients with Acute Traumatic Spinal Cord Injury: A Systematic Review of the LiteratureJournal of Neurotrauma, 2011
- Pain and emotion: a biopsychosocial review of recent researchJournal of Clinical Psychology, 2011
- Influence of a Locomotor Training Approach on Walking Speed and Distance in People With Chronic Spinal Cord Injury: A Randomized Clinical TrialPhysical Therapy, 2011
- Quality of life instruments and definitions in individuals with spinal cord injury: a systematic reviewSpinal Cord, 2009
- Outcome measures in spinal cord injury: recent assessments and recommendations for future directionsSpinal Cord, 2009
- A systematic review of functional ambulation outcome measures in spinal cord injurySpinal Cord, 2007
- Measurement of health statusControlled Clinical Trials, 1989